Children/ Adolescents (6 months to 17 years old)

Influenza vaccination
Influenza vaccination is recommended for all children who are 6 to 59 months old (<5 years old). The vaccine is recommended annually or per season. Singaporean children that fall within this age group are eligible for full vaccination subsidies at CHAS GP clinics and polyclinics.

Influenza vaccination is recommended annually or per season for children and adolescents aged 5 to 17 years old with the following medical conditions:

• Chronic disorders of the pulmonary or cardiovascular systems, including asthma;

• Require medical follow-up or hospitalisation due to chronic metabolic diseases (including diabetes mellitus), renal, neurologic, hepatic, or haematologic disorders;

• Immunosuppression (including immunosuppression caused by medications, HIV or other immunodeficiencies); or

• Are receiving long term aspirin therapy and therefore might be at risk for developing Reye syndrome after influenza infection.

For this group of children and adolescents, individuals are advised to check with their doctor if influenza vaccination is recommended and if their child is eligible for the subsidies.

Pneumococcal vaccinations
Pneumococcal vaccination (pneumococcal conjugate 10-valent or 13-valent, PCV10 or PCV13) is recommended for all children and fully subsidised for Singaporean children at CHAS GP clinics and polyclinics. Previously unvaccinated healthy children aged <5 years and older children with certain medical conditions are recommended to receive PCV. If the child has not been previously vaccinated, individuals are advised to consult their doctor to check if the vaccine is still recommended for their child.

Another type of pneumococcal vaccine (pneumococcal polysaccharide 23-valent, PPSV23), is recommended for children and adolescents aged 2 to 17 years who have any of the following medical conditions:

• Chronic pulmonary, cardiovascular, renal or liver disease, or diabetes mellitus;

• Cochlear implant or cerebrospinal fluid leak;

• Anatomic or functional asplenia (including conditions such as homozygous sickle cell disease and coeliac syndrome that may lead to splenic dysfunction); or

• Immunosuppression (including immunosuppression caused by medications, HIV or other immunodeficiencies).

For this group of children and adolescents, individuals are advised to check with their doctor if PPSV23 is recommended and if their child is eligible for the subsidies.